(Q47835607)

English

Adjuvant requirement for successful immunization with recombinant derivatives of Plasmodium vivax merozoite surface protein-1 delivered via the intranasal route

scientific article published in June 2007

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/17568936

Adjuvant requirement for successful immunization with recombinant derivatives of Plasmodium vivax merozoite surface protein-1 delivered via the intranasal route (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/17568936

Plasmodium vivax

0 references

0 references

Daniel Youssef Bargieri

object named as

Daniel Y Bargieri

1

0 references

Daniela Santoro Rosa

object named as

Daniela S Rosa

2

0 references

author name string

Melissa Ang Simões Lasaro

3

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/17568936

Luis Carlos S Ferreira

4

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/17568936

Irene S Soares

5

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/17568936

Mauricio M Rodrigues

6

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/17568936

publication date

1 June 2007

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/17568936

number of pages

5

1 reference

based on heuristic

inferred from page(s)

Memórias do Instituto Oswaldo Cruz

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/17568936

102

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/17568936

3

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/17568936

313-317

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/17568936

Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides.

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762007005000039

21 January 2018

Comparison of the immunogenic properties of recombinant proteins representing the Plasmodium vivax vaccine candidate MSP1(19) expressed in distinct bacterial vectors

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762007005000039

21 January 2018

Mucosal adjuvants

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762007005000039

21 January 2018

Intranasal immunization with yeast-expressed 19 kD carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein-1 (yMSP119) induces protective immunity to blood stage malaria infection in mice

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762007005000039

21 January 2018

Mucosal immunisation and adjuvants: a brief overview of recent advances and challenges

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762007005000039

21 January 2018

Intranasal immunization with pneumococcal conjugate vaccines with LT-K63, a nontoxic mutant of heat-Labile enterotoxin, as adjuvant rapidly induces protective immunity against lethal pneumococcal infections in neonatal mice

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762007005000039

21 January 2018

Production and release of heat-labile toxin by wild-type human-derived enterotoxigenic Escherichia coli.

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762007005000039

21 January 2018

Effects of cholera toxin on innate and adaptive immunity and its application as an immunomodulatory agent

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762007005000039

21 January 2018

Serological detection of Plasmodium vivax malaria using recombinant proteins corresponding to the 19-kDa C-terminal region of the merozoite surface protein-1

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762007005000039

21 January 2018

The pan HLA DR-binding epitope improves adjuvant-assisted immunization with a recombinant protein containing a malaria vaccine candidate

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762007005000039

21 January 2018

Advances in vaccine adjuvants

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762007005000039

21 January 2018

Recent advances in vaccine adjuvants

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762007005000039

21 January 2018

Identifiers

10.1590/S0074-02762007005000039

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/17568936

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/17568936

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47835607&oldid=2172315018"